metals are associated with susceptibility to numerous infections 11 . Metal availability is a critical factor that affects the outcome of hostpathogen interactions, and metal levels vary widely depending on host diet and environmental exposures 12 . Here we sought to examine the effect of dietary Zn and Zn availability on susceptibility to, and severity of, CDI.
To determine the effect of dietary Zn on CDI, diets containing no Zn (low-Zn diet; 0 mg Zn per kg of diet (mg/kg)), normal amounts of Zn (control diet; 29 mg/kg Zn) or excess amounts of Zn (high-Zn diet; 1,000 mg/kg Zn) were synthesized. The high-Zn diet was designed to model excess Zn supplementation in humans, with approximately 12-fold the Zn level of standard mouse chow (LabDiet 5K52/5K67; LabDiet 5100). Mice were fed altered Zn diets for 5 weeks, during which period no signs of toxicity were observed. Mice fed the high-Zn diet had increased levels of Zn in cecal and colonic tissue, as well as in feces (Fig. 1a-c and Supplementary Fig. 1a) . In contrast, mice fed the low-Zn diet had substantially decreased levels of Zn in these compartments (Supplementary Fig. 1a ). These findings demonstrate that dietary Zn alterations affect cecal and colonic Zn levels.
Diet is an important mediator of microbial community structure 13 ; however, the effect of dietary Zn on the gut microbiota has yet to be elucidated. To examine the effect of Zn on the gut microbiota, feces were collected throughout a 5-week time course of dietary Zn manipulation. Mice fed the high-Zn diet showed decreased microbial diversity and a marked shift in community structure as compared to that in mice fed the control or low-Zn diets (under which conditions the community structure did not significantly differ) ( Fig. 1d and Supplementary Fig. 1b ). Zn-mediated community shifts were observed as early as 1 week following diet alteration ( Supplementary  Fig. 1d ). Characterization of taxa from mice fed the high-Zn diet revealed a significant decrease in operational taxonomic units (OTUs) affiliated with the Turicibacter (OTU 2) and Clostridium (OTU 11) genera, and increases in OTUs affiliated with the Enterococcus (OTU 4) and Clostridium XI (OTU 3) genera ( Fig. 1e) . Excess Zn did not have Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection an effect on the bacterial burden ( Supplementary Fig. 1e ). These data demonstrate that excess dietary Zn alters the diversity and structure of the gut microbiota in mice.
A number of C. difficile virulence factors have a Zn requirement; however, the effect of Zn on CDI has yet to be explored [14] [15] [16] [17] . To test this, we used a mouse model of CDI that induces susceptibility to C. difficile through administration of cefoperazone (0.5 mg/ml) ( Supplementary Fig. 2) 18 . Mice fed the high-Zn diet showed exacerbation of disease, which was highlighted by increased inflammation, epithelial damage and pseudomembrane formation ( Fig. 2  and Supplementary Fig. 3 ). Zn-mediated disease exacerbation was observed following infection with both C. difficile strains 630 (ref. 19 ) (ribotype 012) and R20291 (ref. 20) (ribotype 027), showing that the effect of Zn on CDI is not strain specific ( Fig. 2) . Mice fed the low-Zn diet did not show increased disease, and mice fed altered Zn diets showed no pathology before infection ( Supplementary Fig. 4a-f ). We did not observe significant differences in C. difficile burden between mice given the control and the high-Zn diets (Supplementary Fig. 3) .
To examine the effect of excess Zn on C. difficile virulence, C. difficile toxin A (TcdA)-and toxin B (TcdB)-dependent toxicity was quantified using a cell-rounding assay 18 . Mice fed excess Zn showed increased toxin titers in feces following infection ( Fig. 2b,e ). Cytokine analysis revealed a significant (P < 0.05) increase in interleukin (IL)-1β levels in mice fed excess Zn and infected with R20291 ( Supplementary  Fig. 5 ). Moreover, levels of the pro-inflammatory cytokines IL-6 and IL-12(p70) and the anti-inflammatory cytokine IL-10 were decreased in mice fed excess Zn (Supplementary Fig. 5 ). There were no significant increases in inflammation in mice fed excess Zn before infection ( Supplementary Fig. 6 ). Loss of barrier function and an increase in microbiota translocation is associated with severe CDI and increased IL-1β production 21, 22 . Therefore, the degree of microbiota translocation following infection was examined. Bacterial burdens from livers revealed a marked increase in microbiota translocation associated with CDI in mice fed excess Zn ( Supplementary Fig. 7a,b) . Livers from mice that were fed the control diet and infected with C. difficile were exclusively colonized with members of the Enterobacteriaceae. Livers from mice that were fed excess Zn were colonized with Enterobacteriaceae, Enterococcus and non-C. difficile Clostridium spp. Taken together, these data demonstrate that excess Zn has a profound effect on C. difficile-associated disease.
When we treated mice with antibiotics (0.5 mg/ml cefoperazone), C. difficile burden was not affected by Zn; however, we reasoned that community shifts induced by Zn might lower the threshold of antibiotics needed to confer susceptibility to CDI (Supplementary Fig. 3 ).
To test this hypothesis, mice fed altered diets were treated with 50-fold less cefoperazone (0.01 mg/ml) before infection. This low-level antibiotic treatment did not render mice fed the low-Zn or control diets susceptible to CDI ( Fig. 3a and Supplementary Fig. 8 ). In contrast, mice fed the high-Zn diet were susceptible to CDI and showed severe disease ( Fig. 3a,b) . Mice that were not treated with antibiotics showed no C. difficile colonization for any of the diets. Examination of gut microbiota from mice fed the high-Zn diet followed by low-level antibiotic treatment revealed a complete loss in diversity and a significant shift in the community that mirrored mice given high-level antibiotics (0.5 mg/ml) ( Fig. 3c-e ). In contrast, mice fed the control diet maintained high microbial diversity after low-level antibiotic treatment, which may account for the robust resistance to CDI (Fig. 3c) . These data suggest that excess Zn renders the gut microbiota vulnerable to low-level perturbations and decreases the threshold of antibiotics needed to diminish colonization resistance to C. difficile.
Calprotectin is a Zn-binding protein that has antimicrobial activity against various pathogens [23] [24] [25] [26] . Moreover, fecal calprotectin levels are predictive of disease severity in adults with CDI 27, 28 . To further elucidate the association of calprotectin with CDI, fecal calprotectin was measured in 25 pediatric subjects with CDI. Fecal calprotectin levels were increased in pediatric subjects who showed signs of severe CDI ( Supplementary Table 1 ). Furthermore, increased serum calprotectin levels were associated with increased disease severity in 48 adults with CDI ( Fig. 4a) . However, the role of calprotectin during CDI has yet to be explored.
In culture, C. difficile growth was inhibited by the addition of recombinant calprotectin (1 mg/ml) ( Fig. 4b) . This inhibition was Zn dependent, as either treatment with a calprotectin mutant defective in Zn binding (∆S1/S2) or supplementation with Zn (10 µM ZnCl 2 ) reversed this effect ( Fig. 4b) . Supplementation with manganese (10 µM MnCl 2 ) partially restored growth, but supplementation with iron (10 µM Fe(II)SO 4 ) did not ( Supplementary Fig. 9a,b) . In mice infected with C. difficile, calprotectin was abundant at the site of infection ( Fig. 4c) . To examine the importance of calprotectin during CDI, calprotectin-deficient mice (S100a9 −/− ) 29 were infected with C. difficile strain R20291. Calprotectin-deficient mice showed decreased survival and increased disease severity ( Fig. 4d,e) . In contrast to what was observed in culture, C. difficile burden was not altered in calprotectin-deficient mice (Supplementary Fig. 10 ). This suggests that the kinetics of calprotectin accumulation in the cecum are not sufficient to fully inhibit C. difficile growth in vivo. We hypothesized that exacerbation of disease associated with calprotectin deficiency is mediated by a decreased capacity of these mice to limit Zn availability during CDI. Consistent with this, calprotectin-deficient mice harbor significantly (P < 0.01) higher levels of Zn in their feces than wild-type mice (Supplementary Fig. 10) . To test the contribution of calprotectindependent Zn limitation during infection, calprotectin-deficient mice were fed the low-Zn diet for 5 weeks before infection with C. difficile strain R20291. Under conditions of Zn starvation, calprotectindeficient animals showed significantly less pathology following infection ( Fig. 4e) . These data demonstrate that calprotectin is an essential host factor for combating CDI, and the protective mechanisms of calprotectin are in part due to the ability to limit Zn during infection. Collectively, these data reveal that dietary Zn has an important role in modulating the gut microbiota and that excess Zn in the diet lowers the amount of antibiotic necessary to confer susceptibility to CDI. In addition, increased Zn levels intensify the severity of C. difficile-associated disease, and calprotectin is important for combating C. difficile by limiting Zn availability. This study advances our understanding of the environmental and host factors associated with CDI. Moreover, these findings provide the basis for shaping future prevention and treatment strategies for CDI. Alteration in diet and limitation of excess Zn intake may prove efficacious for the prevention of CDI in high-risk patients and help limit morbidity during CDI.
MeTHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Sequence Read Archive: sequence data obtained in this study have been deposited under accession number SRP067079. 
ONLINe MeTHODS
Mouse husbandry and model of C. difficile infection. Studies were conducted on adult (8-to 12-week old) age-matched male C57BL/6 (Jackson Laboratories) or C57BL/6 S100a9 −/− mice 29 (breeding colony) that were housed in groups of five. All animals were maintained at Vanderbilt University Medical Center Animal Facilities. Individual mice were not randomized after arrival from Jackson Laboratories; however, multiple litters were included in each experimental group, and all animal experiments were independently performed at least twice. Mice were maintained on a standard chow diet (LabDiets; Rodent Chow Diet 5001) unless specified otherwise. Mice were subjected to a previously described model of CDI 18 . Briefly, mice were given cefoperazone in their drinking water (0.5 mg/ml or 0.01 mg/ml) for 5 d. Mice were then given 2 d of recovery before administration of 10 5 spores of C. difficile in PBS via oral gavage. C. difficile strains R20291 and 630 were used, as noted. Prior to infection, each mouse was confirmed to be C. difficile culture negative. Following infection, mice were monitored for signs of severe disease, including inappetence, diarrhea, hunching and weight loss. Mice that exhibited severe disease or weight loss in excess of 20% were humanely euthanized. All animal experiments were approved and performed in compliance with the Institutional Animal Care and Use Committee (IACUC) of Vanderbilt University.
Dietary modulation.
Diets containing altered metal levels were synthesized by Dyets Inc. using the AIN-93M standardized diet 30 . To minimize metal contamination, this l-amino acid-defined AIN-93M base diet was formulated as a Zn-free diet, and the following concentration of Zn was supplemented: control diet: 29 mg/kg; low-Zn diet: 0 mg/kg; high-Zn diet: 1,000 mg/kg. Zn was added as carbonate salts, as specified by the AIN-93M diet 30 . Mice were fed an altered Zn diet starting at 4 weeks of age, and diets were maintained for 5 weeks before infection and throughout the time course of infection. For each separate diet treatment, two cages of mice from separate litters were run in parallel. The amount of diet that was consumed was monitored, and each group was weighed during the time course of diet manipulation to monitor for disease. Each group consumed equal amounts of diet and showed no signs of disease associated with dietary modulation.
Quantification of bacterial burden. C. difficile colony-forming units (CFUs)
were determined during the time course of infection using fecal samples and at the end point of infection using cecal contents. Samples were diluted in PBS and plated on taurocholate cycloserine cefoxitin fructose agar (TCCFA) for quantification of C. difficile burden. Stool samples from antibiotic-treated mice were plated on TCCFA before infection to ensure that mice were C. difficile culture negative before infection with spores. Bacterial burdens in livers were quantified at the end point of infection. Livers were harvested from mice during necropsy and homogenized in 1 ml of sterile PBS. Liver homogenates were serially diluted in PBS and plated in parallel on 5% sheep blood and Luria-Bertani agar plates under aerobic and anaerobic conditions. Following overnight growth, CFUs were quantified, and individual colonies were isolated. Genomic DNA was extracted from each cultivar, and the 16S rRNA gene was sequenced for identification, using the 27F and 1492R universal 16S rRNA gene primers.
Histological analysis. At necropsy, ceca and colons were harvested, fixed in 10% formalin solution and embedded in paraffin. Sections were stained with hemotoxylin and eosin. Each section was given a disease score by a pathologist in a blinded fashion based on previously described criteria 18 . Histological scores were reported as a cumulative score of three independent scoring criteria: inflammation, edema and epithelial cell damage.
C. difficile toxin cytotoxicity assay. C. difficile toxin specific cytotoxicity was determined using a Green African monkey kidney epithelial (Vero) cellrounding cytotoxicity assay 18, 31 . Briefly, fresh fecal samples were normalized to weight, homogenized in sterile PBS and pelleted at 13,000g. Tenfold serial dilutions of supernatants were added to monolayers of Vero cells, and cell-rounding was assessed for each dilution. The presence of C. difficile toxin A and toxin B were confirmed by neutralizing cell-rounding activity with a combined antitoxin (toxin A and toxin B) antisera (Techlab, cat# T5000).
Cytotoxicity data are expressed as the log 10 (reciprocal value of the highest dilution that rounded 100% of the Vero cells).
Cytokine quantification. Cytokine analysis was performed on mice before infection (n = 5/group) and at 2 d following infection (n = 5/group) with C. difficile strain R20291. At necropsy, whole ceca from mice fed altered Zn diets were flash-frozen in liquid nitrogen and frozen at −80 °C. Ceca were thawed, thoroughly homogenized in 1 ml of Pierce IP Lysis Buffer (Thermo Scientific) and pelleted at 4 °C. Supernatants were collected and normalized to total protein content using a Pierce BCA Protein Assay Kit (Thermo Scientific). Cytokine levels were measured using the Milliplex MAP Mouse Cytokine/Chemokine Magnetic Bead Panel (Millipore) and the Luminex Flexmap 3D platform (Luminex).
Preparation of tissue sections for mass spectrometry.
For preparation of ICP-MS, each cecum or colon was aseptically removed, flushed of contents and immediately flash-frozen in metal-free tubes. Samples were digested in Optima-grade nitric acid and heated until complete digestion was achieved. Samples were diluted in Milli-Q ultrapure water before ICP-MS analysis. For LA-ICP-MS, colon samples were flushed of all contents and filled with 25% Optimal Cutting Temperature compound (OCT) (Tissue-Tek) and then frozen in 100% OCT. Ceca were sectioned at 30-µm thickness using a Leica CM 3050S Cryostat (Leica Microsystems, Bannockburn, IL) and mounted to chilled nitric acid-washed polylysine-coated vinyl slides. For MALDI-IMS, tissues were collected fresh and frozen in 25% OCT with all contents intact. Ceca were sectioned at 10-µm thickness and thaw-mounted onto chilled indium-tin oxide-coated slides (Delta Technologies, Loveland, CO).
Mass spectrometry. LA-ICP-MS and ICP-MS were performed as previously described 32 . Briefly, quantitative elemental analysis was performed on a Thermo Element 2 high-resolution sector field inductively coupled plasma mass spectrometer (ICP-MS; Thermo Fisher Scientific, Bremen, Germany). Elemental imaging was performed by using a laser ablation system (LA; LSX-213; CETAC. Omaha, NE) coupled with a high-resolution sector field ICP-MS. Slides containing ceca were ablated with a focused Nd:YAG laser beam and transported by helium gas to the ablation cell, mixed with argon gas and then introduced to the ICP-MS. LA-ICP-MS images are represented as relative Zn intensity. For ICP-MS, Zn concentrations were normalized to sample weight and are represented in parts per billion (p.p.b.). For MALDI-IMS, sections were sequentially washed to remove interfering lipids, salts and OCT, using 70% ethanol for 30 s, 100% ethanol for 30 s, 6:2:1 ethanol:chloroform:acetic acid for 2 min, 70% ethanol for 30 s and 100% ethanol for 30 s. Slides were allowed to dry in a desiccator before MALDI matrix was applied. 2,5dihydroxyacetophenone (15 mg/ml) was prepared in 90% acetonitrile with 0.2% trifluoracetic acid and sonicated for 10 min to dissolve all of the crystals. Matrix was applied using a TM-Sprayer (HTX Imaging, Carrboro, NC) operated at 1,100 mm/min. Six passes of matrix were applied to the surface at a flow rate of 0.2 ml/min using 90% acetonitrile as a pushing solvent. The track spacing was set to 2 mm, and the spray nozzle was heated to 80 °C. The coating was rehydrated using 1 ml of 50 mM acetic acid in a sealed hydration chamber at 85 °C for 3 min. IMS was performed using a rapifleX MALDI Tissuetyper (Bruker Daltonics, Billerica, MA) operated in linear positive-ion mode. The laser was operated in single mode (beam width of ≈5 µm) and pixels were set to be 50 × 50 µm. A total of 500 laser shots were captured per pixel, with 50 laser shots at each position. The laser was operated at 10,000 Hz. Data were processed using fleXimaging version 4.1. Data were further analyzed using SCiLS Lab 2015b version 3.02.7774 (Bruker Daltonics). Spectra were normalized to total ion count, and baseline values were subtracted using a top-hat algorithm. The images are displayed without denoising but with interpolation turned on.
DNA extraction and 16S rRNA gene sequencing. Fecal samples were collected fresh from individual mice during the time course of diet manipulation and immediately frozen for storage at −20 °C. For analysis of the microbiota following antibiotic treatment, fecal samples were collected fresh during the 2-d recovery period following cefoperazone treatment. Microbiota analysis was performed for randomly selected mice (n = 5/group) representing both sets of cages in each diet group. Microbial genomic DNA was extracted using the PowerSoil DNA isolation kit (MO BIO Laboratories). The V4 region of the 16S rRNA gene from each sample was amplified and sequenced using the Illumina MiSeq Personal Sequencing platform as described elsewhere 33 . Sequences were curated as described previously using the mothur software package 34 . Briefly, we reduced sequencing and PCR errors, aligned the resulting sequences to the SILVA 16S rRNA sequence database 35 and removed any chimeric sequences flagged by UCHIME 36 . After curation, we obtained between 1,436 and 67,633 sequences per sample (median = 39,487), with a median length of 253 bp. We did not observe any correlation between treatment group and number of sequence reads. To limit effects of uneven sampling, we rarefied the data set to 14,659 sequences per sample. FASTQ sequence data obtained in this study has been deposited to the Sequence Read Archive (SRA) at NCBI under accession number SRP067079.
Analysis of the gut microbiota. Sequences were clustered into OTUs based on a 3% distance cutoff calculated using the average-neighbor algorithm. All sequences were classified using the RDP training set (version 9), and OTUs were assigned a classification based on the taxonomy that had the majority consensus of sequences within each OTU using a naive Bayesian classifier 37 . Sequences that were binned to OTUs that classified as Clostridium XI were individually classified and confirmed to be non-C. difficile members of the Clostridium XI genus. Microbial diversity (α-diversity) was calculated using the inverse Simpson index 38 . Species richness was calculated using Sobs (observed OTUs) 34 . β-diversity was calculated using the θ YC distance metric with OTU frequency data 39 .
16S rRNA gene qPCR analysis. Relative bacterial load in the gut microbiota of mice fed altered Zn diets was measured using universal 16S rRNA gene qPCR primers (F, ACTCCTACGGGAGGCAGCAGT; R, ATTACCGCGGCTG CTGGC) 40 . Samples were normalized to host DNA using primers specific for tumor necrosis factor (Tnf; which encodes TNF-α) (F; GGCTTTCCGAATTCACTGGAG; R, CCCCGGCCTTCCAAATAAA) 3 . qPCR was performed on genomic DNA isolated from stool using IQ SYBR Green Supermix (Bio-Rad). Note that qPCR measures relative fold change of the 16S rRNA gene copy number in a sample, not overall bacterial numbers.
Growth in the presence of recombinant calprotectin. C. difficile growth curves were performed following a 1:50 dilution of overnight R20291 or 630 cultures. Recombinant calprotectin was supplemented into medium at specified concentrations. Medium consisted of 50% calprotectin buffer and 50% brain-heart infusion medium supplemented with yeast extract, supplemented with 3 mM calcium chloride 25 . A Zn-and Mn-binding mutant with inactivating mutations in sequences encoding both calprotectin metal-binding sites 41 was used as specified. Growth curves were quantified using optical density (OD 600 ) at 37 °C under anoxic conditions. Growth medium was supplemented with Zn (10 ZnCl 2 ), Mn (MnCl 2 ) or Fe(II) (FeSO 4 ) to evaluate growth rescue. Metal supplementation of medium was performed immediately before addition of C. difficile and incubation for growth. Each growth curve was performed at least three independent times, and representative growth curves were selected. Fecal calprotectin. Fecal calprotectin levels were measured on 25 pediatric patients diagnosed with CDI. Subjects were enrolled at two tertiary-care children's hospitals (Monroe Carrell Jr. Children's Hospital, Nashville, Tennessee and Texas Children's Hospital, Houston, Texas). The Institutional Review Boards of the participating institutions reviewed and approved the study (IRB 130315). Consent was obtained from all subjects in the study. Hospital laboratory records were used to identify individuals who tested positive for C. difficile at the time of diagnosis. Both hospitals use molecular-based assays to test stool for the presence of toxigenic C. difficile. Children aged between 12 months and 18 years with CDI were eligible for enrollment. CDI was defined as a positive C. difficile diagnostic test and diarrhea. Subjects were excluded from the study if an alternative enteropathogen was identified by routine clinical testing requested by the primary medical team. Fecal samples were thawed and normalized to weight, and fecal calprotectin was measured using the Calprotectin ELISA Assay Kit (Eagle Biosciences, Nashua, NH).
Measurement

Statistical analyses.
Statistical analyses were performed using GraphPad Prism (Version 6.0) and R (Version 3.1.0). The Mann-Whitney test was used for comparisons of continuous variables between two treatment groups. Analysis of molecular variance (AMOVA) was performed to determine significance between the community structures of different groups of samples based on θ YC distance matrices 43 . The machine-learning algorithm 'random forest' was implemented using the randomForest R package to identify features (OTUs) differentially abundant in each dietary group and to further assess gut microbiota variation between dietary groups (http://CRAN.R-project. org) 44 . Repeated-measure paired-treatment ANOVA for each OTU was used to identify OTUs important for driving differences between dietary groups. We corrected for multiple comparisons using an experiment-wise error rate of 0.01 and controlled for false discovery rate using the Benjamani-Hochberg method 45 . For survival analysis, the log-rank test was used to evaluate significance between groups. A sample size of at least five per group was used for animal experiments. Power analyses were not performed before animal studies. Sample size for our human serum calprotectin study was determined by retrospectively selecting all available C. difficile-positive subjects from the VALID study 42 . Samples size for our pediatric fecal calprotectin study was based on the anticipated and achieved collection of stool samples obtained during a Thrasher-funded 14-month study at two tertiary-care children's hospitals. Whenever feasible, blinding was performed during experimentation and analyses (DNA extraction from stool, 16S rRNA sequence curation and analysis, ICP-MS analysis, calprotectin ELISA analyses, survival analysis in calprotectin-deficient animals and pathology scoring). To avoid Zn contamination during diet manipulation, diet treatment groups were not blinded. No mice were excluded from analysis.
